You are here

A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Royal Liverpool Hospital
Liverpool, Merseyside, L7 8XP United Kingdom
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Chronic Myeloid Leukaemia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 +
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diagnosis of Ph+ CML aged ≥18 years at bosutinib initiation.

- Prescribed bosutinib (irrespective of the phase of their disease) EITHER in normal
clinical practice since it received marketing authorisation (27th March 2013) by the
EMA11 OR via the compassionate use programme prior to marketing authorization.

- Where required, evidence of a personally signed and dated informed consent document
indicating that the patient (or a legally acceptable representative) has been informed
of all pertinent aspects of the study.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Prescribed bosutinib as part of an interventional clinical trial programme.

- Initiated on bosutinib less than 3 months prior to data collection taking place.

NCT02546375
Pfizer
Completed
A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Chronic Myeloid Leukaemia
NCT02546375
All Genders
0+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now